Clinical trial / 2010
DHA supplementation during the second half of pregnancy did not reduce maternal postpartum depression or improve child neurodevelopment at 18 months.
In the DOMInO trial, 2399 pregnant women were randomized to receive 800 mg/d DHA via fish oil capsules or matched vegetable oil capsules without DHA until birth. High postpartum depressive symptoms occurred in 9.67% of women in the DHA group and 11.19% in the control group (adjusted RR, 0.85; 95% CI, 0.70-1.02; P = .09). Among children followed at 18 months, mean cognitive composite scores (adjusted mean difference, 0.01; 95% CI, -1.36 to 1.37; P = .99) and mean language composite scores (adjusted mean difference, -1.42; 95% CI, -3.07 to 0.22; P = .09) did not differ significantly between groups.
- Study type
- Double-blind, multicenter, randomized controlled trial
- Who was studied
- 2399 pregnant women with singleton pregnancies (<21 weeks' gestation) across 5 Australian maternity hospitals
- What was measured
- Maternal depressive symptoms (Edinburgh Postnatal Depression Scale >12) and child cognitive and language development at 18 months
THE PAPER
Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial.
Makrides M, Gibson RA, McPhee AJ, Yelland L, Quinlivan J, Ryan P, DOMInO Investigative Team. JAMA, 2010.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.